Avanos Medical (AVNS) Net Margin (2013 - 2026)
Avanos Medical recorded quarterly Net Margin of 2.8% in Q1 2026, up 1775.74% quarter-over-quarter from 0.17% in Q4 2024.
Avanos Medical's Net Margin history runs 12 years deep, the most recent figure standing at 2.8% for Q1 2026.
- In Q1 2026, Net Margin changed N/A year-over-year to 2.8%; the TTM figure through Mar 2026 stood at 0.71% (up 135.0% YoY), while the FY2024 annual figure was 0.84%, up 687.0% from the prior year.
- Net Margin came in at 2.8% for Q1 2026 at Avanos Medical, up from 0.17% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 4.58% in Q1 2023 to a low of 37.66% in Q2 2023.
- A 4-year average of 1.31% and a median of 2.73% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin soared 7575 bps in 2022 and tumbled 4217 bps in 2023, its largest moves.
- Avanos Medical's Net Margin stood at 3.96% in 2022, then tumbled by 107 bps to 0.29% in 2023, then surged by 42 bps to 0.17% in 2024, then jumped by 1776 bps to 2.8% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 2.8%, 0.17%, and 0.94% for Q1 2026, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 2.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.80% |
| Dec 31, 2024 | -0.17% |
| Sep 30, 2024 | -0.94% |
| Jun 30, 2024 | -1.46% |
| Mar 31, 2024 | -0.84% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | 2.98% |
| Jun 30, 2023 | -37.66% |
| Mar 31, 2023 | 4.58% |
| Dec 31, 2022 | 3.96% |
| Sep 30, 2022 | 2.73% |
| Jun 30, 2022 | 4.51% |
| Mar 31, 2022 | 2.74% |
| Dec 31, 2021 | -71.79% |
| Sep 30, 2021 | -19.17% |
| Jun 30, 2021 | 20.65% |
| Mar 31, 2021 | -4.65% |
| Dec 31, 2020 | -26.49% |
| Sep 30, 2020 | 10.39% |
| Jun 30, 2020 | -1.83% |
| Mar 31, 2020 | 2.05% |
| Dec 31, 2018 | 0.29% |
| Jun 30, 2018 | 21.13% |
| Mar 31, 2018 | 20.14% |
| Dec 31, 2017 | 17.08% |
| Sep 30, 2017 | 17.81% |
| Jun 30, 2017 | 19.11% |
| Mar 31, 2017 | 19.01% |
| Dec 31, 2016 | 18.36% |
| Sep 30, 2016 | 2.29% |
| Jun 30, 2016 | 1.63% |
| Mar 31, 2016 | 3.69% |
| Dec 31, 2015 | -51.14% |
| Sep 30, 2015 | -120.80% |
| Jun 30, 2015 | 2.05% |
| Mar 31, 2015 | 5.50% |
| Dec 31, 2014 | -0.55% |
| Sep 30, 2014 | -1.81% |
| Jun 30, 2014 | -1.09% |
| Mar 31, 2014 | 10.08% |
| Dec 31, 2013 | 9.23% |
| Sep 30, 2013 | 11.42% |